Market Tracker

07/29 4:26am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

302.16
Data as of Jul 28
 -0.93 / -0.31%
Today’s Change
227.64
Today|||52-Week Range
352.49
+9.78%
Year-to-Date

Today’s Trading

Previous close303.09
Today’s open302.25
Day’s range299.73 - 303.62
Volume531,180
Average volume (3 months)819,508
Market cap$30.6B
Dividend yield--
Data as of 07/28/2014

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)+20.73%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+52.69%
P/E ratio84.9
Price/Sales12.80
Price/Book15.48

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.19-0.35%
CBSTCubist Pharmaceutica...-1.11-1.78%
ALNYAlnylam Pharmaceutic...-1.52-2.77%
IDIXIdenix Pharmaceutica...-0.01-0.04%
Data as of 07/28/2014

Financials

Next reporting dateAugust 5, 2014
EPS forecast (this quarter)$2.27
Annual revenue (last year)$2.1B
Annual profit (last year)$424.4M
Net profit margin20.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts